Search
Add filters:
Use filters to refine the search results.
Results 1-5 of 5 (Search time: 0.009 seconds).
- previous
- 1
- next
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
1-Sep-2016 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus | Feliubadaló i Elorza, Maria Lídia; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); KConFab Investigators; Australian Ovarian Cancer Study Group |
31-Dec-2014 | Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers | Lázaro García, Conxi; Blanco Guillermo, Ignacio; Teulé-Vega, Àlex; Menéndez Vilà, Mireia; Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); KConFab Investigators |
21-Jun-2016 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus | Lázaro García, Conxi; Teulé-Vega, Àlex; Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); KConFab Investigators; AOCS Investigators |
Apr-2016 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 | Pujana Genestar, M. Ángel; EMBRACE Collaborators; GEMO Study Collaborators; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) |
9-Feb-2016 | Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 | Pujana Genestar, M. Ángel; KConFab Investigators; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE) |
Discover
Subject